P3 Health Partners (PIIIW) Competitors $0.01 0.00 (0.00%) As of 07/11/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock PIIIW vs. ACONW, AONC, DHACW, FMS, LFMDP, OTRKP, TALKW, TOIIW, VSEE, and NTRAShould you be buying P3 Health Partners stock or one of its competitors? The main competitors of P3 Health Partners include Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), Fresenius Medical Care AG & Co. KGaA (FMS), LifeMD (LFMDP), Ontrak (OTRKP), Talkspace (TALKW), Oncology Institute (TOIIW), VSee Health (VSEE), and Natera (NTRA). These companies are all part of the "healthcare" industry. P3 Health Partners vs. Its Competitors Aclarion American Oncology Network Digital Health Acquisition Fresenius Medical Care AG & Co. KGaA LifeMD Ontrak Talkspace Oncology Institute VSee Health Natera Aclarion (NASDAQ:ACONW) and P3 Health Partners (NASDAQ:PIIIW) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and media sentiment. Does the media refer more to ACONW or PIIIW? In the previous week, Aclarion and Aclarion both had 2 articles in the media. P3 Health Partners' average media sentiment score of 0.94 beat Aclarion's score of 0.63 indicating that P3 Health Partners is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aclarion 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive P3 Health Partners 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is ACONW or PIIIW more profitable? Company Net Margins Return on Equity Return on Assets AclarionN/A N/A N/A P3 Health Partners N/A N/A N/A Which has preferable earnings & valuation, ACONW or PIIIW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAclarion$54.60KN/AN/AN/AN/AP3 Health Partners$1.49BN/AN/AN/AN/A SummaryP3 Health Partners beats Aclarion on 2 of the 2 factors compared between the two stocks. Get P3 Health Partners News Delivered to You Automatically Sign up to receive the latest news and ratings for PIIIW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PIIIW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PIIIW vs. The Competition Export to ExcelMetricP3 Health PartnersMedical Care Facilities IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$1.54B$5.56B$9.11BDividend YieldN/A4.04%5.06%4.01%P/E RatioN/A7.0428.2620.26Price / SalesN/A14.11436.61101.35Price / CashN/A12.3237.1257.67Price / BookN/A2.028.045.49Net IncomeN/A$58.06M$3.19B$250.45M7 Day PerformanceN/A0.10%3.62%4.78%1 Month PerformanceN/A3.15%5.98%9.58%1 Year PerformanceN/A43.32%29.39%16.41% P3 Health Partners Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PIIIWP3 Health PartnersN/A$0.01flatN/AN/A$0.00$1.49B0.00500Positive NewsGap UpACONWAclarionN/A$0.03+0.7%N/A-34.8%$0.00$54.60K0.007Gap DownAONCAmerican Oncology NetworkN/A$12.51-6.6%N/A+686.8%$0.00$1.34B0.001,520DHACWDigital Health AcquisitionN/A$0.05-0.2%N/AN/A$0.00N/A0.00N/AFMSFresenius Medical Care AG & Co. KGaA3.4197 of 5 stars$27.49-0.1%$27.80+1.1%+35.9%$0.00$20.63B24.541,384Positive NewsLFMDPLifeMDN/A$23.05-0.7%N/A+4.6%$0.00$234.01M0.00230Positive NewsHigh Trading VolumeOTRKPOntrakN/A$0.23-4.7%N/A-8.3%$0.00$10.84M0.00250Positive NewsGap UpHigh Trading VolumeTALKWTalkspaceN/A$0.09-9.0%N/A-10.2%$0.00$194.36M0.00500Positive NewsGap UpTOIIWOncology InstituteN/A$0.08+13.9%N/A+235.7%$0.00$403.15M0.00660Positive NewsVSEEVSee Health1.1035 of 5 stars$1.23+7.0%$5.00+306.5%-81.2%$0.00N/A0.00N/AGap UpNTRANatera1.6524 of 5 stars$161.75+2.1%$184.63+14.1%+43.8%$21.64B$1.70B-110.034,434 Related Companies and Tools Related Companies Aclarion Competitors American Oncology Network Competitors Digital Health Acquisition Competitors Fresenius Medical Care AG & Co. KGaA Competitors LifeMD Competitors Ontrak Competitors Talkspace Competitors Oncology Institute Competitors VSee Health Competitors Natera Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PIIIW) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding P3 Health Partners Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share P3 Health Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.